F. D. Goebel

1.8k total citations
52 papers, 1.3k citations indexed

About

F. D. Goebel is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, F. D. Goebel has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Virology, 21 papers in Infectious Diseases and 21 papers in Epidemiology. Recurrent topics in F. D. Goebel's work include HIV Research and Treatment (30 papers), HIV/AIDS drug development and treatment (15 papers) and Cytomegalovirus and herpesvirus research (11 papers). F. D. Goebel is often cited by papers focused on HIV Research and Treatment (30 papers), HIV/AIDS drug development and treatment (15 papers) and Cytomegalovirus and herpesvirus research (11 papers). F. D. Goebel collaborates with scholars based in Germany, France and Italy. F. D. Goebel's co-authors include Johannes R. Bogner, Rika Draenert, J. Röling, Michael Fischereder, Holger Schmid, Ravi Walli, Volker Erfle, Antonio Cosma, Gerd Sutter and Dirk H. Busch and has published in prestigious journals such as Clinical Infectious Diseases, The FASEB Journal and The Journal of Infectious Diseases.

In The Last Decade

F. D. Goebel

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. D. Goebel Germany 19 666 655 405 297 182 52 1.3k
Bonnie M. Slike United States 20 585 0.9× 549 0.8× 303 0.7× 286 1.0× 291 1.6× 37 1.6k
Mostafa Nokta United States 19 455 0.7× 414 0.6× 86 0.2× 439 1.5× 221 1.2× 48 1.1k
Barry M. Bredt United States 19 1.2k 1.7× 758 1.2× 467 1.2× 954 3.2× 844 4.6× 21 2.4k
Sonia Zicari United States 17 309 0.5× 310 0.5× 158 0.4× 219 0.7× 256 1.4× 34 1.1k
Bo Hofmann Denmark 23 941 1.4× 559 0.9× 84 0.2× 523 1.8× 1.0k 5.6× 55 2.0k
Carolina Gutiérrez Spain 16 586 0.9× 456 0.7× 153 0.4× 216 0.7× 195 1.1× 33 919
Patricia M. Hultin United States 18 783 1.2× 341 0.5× 230 0.6× 321 1.1× 862 4.7× 23 1.5k
Sulggi A. Lee United States 21 711 1.1× 785 1.2× 300 0.7× 354 1.2× 324 1.8× 37 1.4k
Lorrie Epling United States 17 1.3k 2.0× 801 1.2× 576 1.4× 567 1.9× 785 4.3× 21 2.0k
Winston Cavert United States 15 1.8k 2.7× 1.3k 2.0× 460 1.1× 508 1.7× 731 4.0× 25 2.5k

Countries citing papers authored by F. D. Goebel

Since Specialization
Citations

This map shows the geographic impact of F. D. Goebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. D. Goebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. D. Goebel more than expected).

Fields of papers citing papers by F. D. Goebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. D. Goebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. D. Goebel. The network helps show where F. D. Goebel may publish in the future.

Co-authorship network of co-authors of F. D. Goebel

This figure shows the co-authorship network connecting the top 25 collaborators of F. D. Goebel. A scholar is included among the top collaborators of F. D. Goebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. D. Goebel. F. D. Goebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dembek, Claudia J., Johannes R. Bogner, Ulrike Protzer, et al.. (2010). MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays. Gene Therapy. 17(11). 1372–1383. 13 indexed citations
2.
Mühlhöfer, A, J. R. Bogner, & F. D. Goebel. (2008). HIV-Viruslast: neue Aspekte und Grenzen der klinischen Anwendung. DMW - Deutsche Medizinische Wochenschrift. 121(42). 1303–1308.
3.
Cosma, Antonio, Caroline Staib, Franziska Wopfner, et al.. (2007). Evaluation of Modified Vaccinia Virus Ankara as an Alternative Vaccine against Smallpox in Chronically HIV Type 1-Infected Individuals Undergoing HAART. AIDS Research and Human Retroviruses. 23(6). 782–793. 25 indexed citations
4.
Röling, J., Holger Schmid, Michael Fischereder, Rika Draenert, & F. D. Goebel. (2006). HIV-Associated Renal Diseases and Highly Active Antiretroviral Therapy--Induced Nephropathy. Clinical Infectious Diseases. 42(10). 1488–1495. 160 indexed citations
5.
Goebel, F. D., Anton Pozniak, Elena Vinogradova, et al.. (2006). Short-term antiviral activity of TMC278 – a novel NNRTI – in treatment-naive HIV-1-infected subjects. AIDS. 20(13). 1721–1726. 103 indexed citations
6.
Jülg, Boris & F. D. Goebel. (2005). What’s New in HIV/AIDS? Chemokine Receptor Antagonists: A New Era of HIV Therapy?. Infection. 33(5-6). 408–410. 2 indexed citations
7.
8.
Michl, Gerlinde M., Ravi Walli, Johannes R. Bogner, et al.. (2001). Alterations of Apolipoprotein B Metabolism in HIV-Infected Patients With Antiretroviral Combination Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(3). 225–235. 49 indexed citations
9.
Rolinski, Boris, et al.. (1999). Endothelin-1 1s Elevated in the Cerebrospinal Fluid of HIV-Infected Patients with Encephalopathy. Infection. 27(4-5). 244–247. 18 indexed citations
10.
Sporer, Bernd, et al.. (1998). Presence of Matrix Metalloproteinase‐9 Activity in the Cerebrospinal Fluid of Human Immunodeficiency Virus—Infected Patients. The Journal of Infectious Diseases. 178(3). 854–857. 80 indexed citations
11.
Malo, Antje, Johannes R. Bogner, Rudi Gruber, et al.. (1998). Lack of Protection from HIV infection by the Mutant HIV Coreceptor CCR5 in Intravenously HIV Infected Hemophilia Patients. Immunobiology. 198(4). 485–488. 4 indexed citations
12.
Schatz, Octavian, Johannes R. Bogner, & F. D. Goebel. (1997). Kaposi's sarcoma: is the hunt for the culprit over now?. Journal of Molecular Medicine. 75(1). 28–34. 2 indexed citations
13.
Rolinski, Boris, et al.. (1995). Das okuläre Mikroangiopathie-Syndrom bei Patienten mit AIDS ist mit erhöhten Plasma-Spiegeln des Vasokonstriktors Endothelin-1 assoziiert. Klinische Monatsblätter für Augenheilkunde. 207(12). 353–360. 8 indexed citations
14.
Bogner, J. R., et al.. (1994). Insulin-dependent diabetes mellitus following pentamidine therapy in a patient with AIDS. Journal of Molecular Medicine. 72(12). 1027–1029. 6 indexed citations
15.
Bogner, Johannes R., et al.. (1993). Impairment of tritan colour vision after initiation of treatment with zidovudine in patients with HIV disease or AIDS.. British Journal of Ophthalmology. 77(5). 315–316. 13 indexed citations
16.
17.
Kleinschmidt, A., et al.. (1991). Serological markers as prognostic criteria for the course of HIV infection. Infection. 19(S2). S89–S92. 1 indexed citations
18.
Ehrenreich, Hannelore, Fred Sinowatz, Rüdiger Schulz, R Arendt, & F. D. Goebel. (1989). Immunoreactive atrial natriuretic peptide (ANP) in endoscopic biopsies of the human gastrointestinal tract. Research in Experimental Medicine. 189(6). 421–425. 14 indexed citations
19.
Pfister, H.-W., Manfred Wick, A. Fateh‐Moghadam, et al.. (1989). Myelin basic protein in the cerebrospinal fluid of patients infected with HIV. Journal of Neurology. 236(5). 288–291. 9 indexed citations
20.
Erfle, Volker, Rüdiger Hehlmann, W. Mellert, et al.. (1985). Prevalence of antibodies to human T-lymphotropic virus-III (HTLV-III) in hemopheliacs and other patients chronically substituted with blood products. Annals of Hematology. 51(4). 243–249. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bonnie M. Slike Breakdown of academic impact, for papers by Mostafa Nokta Breakdown of academic impact, for papers by Barry M. Bredt Breakdown of academic impact, for papers by Sonia Zicari Breakdown of academic impact, for papers by Bo Hofmann Breakdown of academic impact, for papers by Carolina Gutiérrez Breakdown of academic impact, for papers by Patricia M. Hultin Breakdown of academic impact, for papers by Sulggi A. Lee Breakdown of academic impact, for papers by Lorrie Epling Breakdown of academic impact, for papers by Winston Cavert
Rankless by CCL
2026